Barchart on MSN19d
Eton Pharma - Small Cap That's Climbing
Summary The Chart of the Day belongs to the pharmaceutical company Eton Pharmaceuticals (ETON) . I found the stock by using ...
Endocrinology Advisor4d
Adrenal Mass Malignancy Predictors Include Rapid Growth, Right-Sided Laterality
Adrenal mass malignancy predictors included rapid growth rate, hormonal overproduction, and right-sided laterality.
Finanznachrichten2d
Checkpoint Therapeutics, Inc: Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (cosibelimab-ipdl)
Immune-mediated colitis occurred in 0.4% (1/223, Grade 1) of patients receiving UNLOXCYT. UNLOXCYT can cause primary or secondary adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, ...
Neurocrine's CRENESSITY Gains FDA Approval For Treating Congenital Adrenal Hyperplasia
Neurocrine Biosciences, Inc. (NBIX) said that the U.S. Food and Drug Administration has approved CRENESSITY (crinecerfont) capsules ...
Morningstar10d
IMFINZI® (durvalumab) granted Priority Review in the US for patients with muscle-invasive bladder cancer
Immune-Mediated Endocrinopathies Adrenal Insufficiency:IMFINZI and IMJUDO can cause primary or secondary adrenal insufficiency. For Grade 2 or higher adrenal insufficiency, initiate symptomatic ...
rheumatologyadvisor10d
STEMI Hospitalization Outcomes Linked to Adrenal Insufficiency Status
Patients with adrenal insufficiency had worse outcomes than those without adrenal insufficiency when hospitalized for STEMI. Among patients with ST elevation myocardial infarction (STEMI), comorbid ...
Yahoo Finance27d
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
RAHWAY, N.J., November 19, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the pivotal Phase 3 MK ...